Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Analysis 2016-2020 and Forecast 2021-2026

Table of Contents

1 Industry Overview

1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

1.2.2 Downstream

Table Application Segment of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market by Type

3.1 By Type

3.1.1 SGD-2083 

Table Major Company List of SGD-2083 

3.1.2 Crizanlizumab 

Table Major Company List of Crizanlizumab 

3.1.3 PF-04447943 

Table Major Company List of PF-04447943 

3.1.4 NVX-508 

Table Major Company List of NVX-508 

3.1.5 Others 

Table Major Company List of Others 

3.2 Market Size

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Type, in USD Million

Figure Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Growth 2016-2020, by Type, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Type, in Volume

Figure Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Type, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 AstraZeneca Plc  (Company Profile, Sales Data etc.)

4.1.1 AstraZeneca Plc  Profile

Table AstraZeneca Plc  Overview List

4.1.2 AstraZeneca Plc  Products & Services

4.1.3 AstraZeneca Plc  Business Operation Conditions

Table Business Operation of AstraZeneca Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Bristol-Myers Squibb Company  (Company Profile, Sales Data etc.)

4.2.1 Bristol-Myers Squibb Company  Profile

Table Bristol-Myers Squibb Company  Overview List

4.2.2 Bristol-Myers Squibb Company  Products & Services

4.2.3 Bristol-Myers Squibb Company  Business Operation Conditions

Table Business Operation of Bristol-Myers Squibb Company  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Gilead Sciences Inc  (Company Profile, Sales Data etc.)

4.3.1 Gilead Sciences Inc  Profile

Table Gilead Sciences Inc  Overview List

4.3.2 Gilead Sciences Inc  Products & Services

4.3.3 Gilead Sciences Inc  Business Operation Conditions

Table Business Operation of Gilead Sciences Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Modus Therapeutics Holding AB  (Company Profile, Sales Data etc.)

4.4.1 Modus Therapeutics Holding AB  Profile

Table Modus Therapeutics Holding AB  Overview List

4.4.2 Modus Therapeutics Holding AB  Products & Services

4.4.3 Modus Therapeutics Holding AB  Business Operation Conditions

Table Business Operation of Modus Therapeutics Holding AB  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Novartis AG  (Company Profile, Sales Data etc.)

4.5.1 Novartis AG  Profile

Table Novartis AG  Overview List

4.5.2 Novartis AG  Products & Services

4.5.3 Novartis AG  Business Operation Conditions

Table Business Operation of Novartis AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 NuvOx Pharma LLC  (Company Profile, Sales Data etc.)

4.6.1 NuvOx Pharma LLC  Profile

Table NuvOx Pharma LLC  Overview List

4.6.2 NuvOx Pharma LLC  Products & Services

4.6.3 NuvOx Pharma LLC  Business Operation Conditions

Table Business Operation of NuvOx Pharma LLC  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Pfizer Inc  (Company Profile, Sales Data etc.)

4.7.1 Pfizer Inc  Profile

Table Pfizer Inc  Overview List

4.7.2 Pfizer Inc  Products & Services

4.7.3 Pfizer Inc  Business Operation Conditions

Table Business Operation of Pfizer Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Seattle Genetics Inc  (Company Profile, Sales Data etc.)

4.8.1 Seattle Genetics Inc  Profile

Table Seattle Genetics Inc  Overview List

4.8.2 Seattle Genetics Inc  Products & Services

4.8.3 Seattle Genetics Inc  Business Operation Conditions

Table Business Operation of Seattle Genetics Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Revenue 2016-2020, by Company, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Revenue Share in 2020, by Company, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume 2016-2020, by Company, in Volume

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration, in 2020

Figure Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Market Concentration, in 2020

Figure Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug MMarket Concentration, in 2020

Figure South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration, in 2020

Figure Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Clinic 

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Clinic , 2016-2020, in USD Million

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Clinic , 2016-2020, in Volume

6.1.2 Demand in Hospital 

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Hospital , 2016-2020, in USD Million

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Hospital , 2016-2020, in Volume

6.1.3 Demand in Others

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Others, 2016-2020, in USD Million

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand in Others, 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand Forecast 2021-2026, by Application, in USD Million

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Growth 2021-2026, by Application, in USD Million

Figure Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share in 2026, by Application, in USD Million

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand Forecast 2021-2026, by Application, in Volume

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Growth 2021-2026, by Application, in Volume

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Production 2016-2020, by Region, in USD Million

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Region, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share 2016-2020, by Region, in USD Million

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Region, in Volume

Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in USD Million

Figure North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

Table North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in USD Million

Figure Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

Table Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in USD Million

Figure South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

Table South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Region, in USD Million

Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table

1. Table Upstream Segment of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

2. Table Application Segment of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug

3. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2026, by Application, in USD Million

4. Table Major Company List of Crizanlizumab 

5. Table Major Company List of PF-04447943 

6. Table Major Company List of NVX-508 

7. Table Major Company List of Others 

8. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Type, in USD Million

9. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Type, in Volume

10. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Type, in USD Million

11. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Type, in Volume

12. Table AstraZeneca Plc  Overview List

13. Table Business Operation of AstraZeneca Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

14. Table Bristol-Myers Squibb Company  Overview List

15. Table Business Operation of Bristol-Myers Squibb Company  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

16. Table Gilead Sciences Inc  Overview List

17. Table Business Operation of Gilead Sciences Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

18. Table Modus Therapeutics Holding AB  Overview List

19. Table Business Operation of Modus Therapeutics Holding AB  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

20. Table Novartis AG  Overview List

21. Table Business Operation of Novartis AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

22. Table NuvOx Pharma LLC  Overview List

23. Table Business Operation of NuvOx Pharma LLC  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

24. Table Pfizer Inc  Overview List

25. Table Business Operation of Pfizer Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

26. Table Seattle Genetics Inc  Overview List

27. Table Business Operation of Seattle Genetics Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

28. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Revenue 2016-2020, by Company, in USD Million

29. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Revenue Share 2016-2020, by Company, in USD Million

30. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume 2016-2020, by Company, in Volume

31. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume Share 2016-2020, by Company, in Volume

32. Table Regional Demand Comparison List

33. Table Major Application in Different Regions

34. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand Forecast 2021-2026, by Application, in USD Million

35. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Demand Forecast 2021-2026, by Application, in Volume

36. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Growth 2021-2026, by Application, in Volume

37. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share in 2026, by Application, in Volume

38. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Production 2016-2020, by Region, in USD Million

39. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Production 2016-2020, by Region, in Volume

40. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Region, in USD Million

41. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share 2016-2020, by Region, in USD Million

42. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2016-2020, by Region, in Volume

43. Table Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share 2016-2020, by Region, in Volume

44. Table North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

45. Table North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

46. Table Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

47. Table Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

48. Table Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

49. Table Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

50. Table South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

51. Table South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

52. Table Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in USD Million

53. Table Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size 2016-2020, by Country, in Volume

54. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Region, in USD Million

55. Table Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast 2021-2026, by Region, in Volume

56. Table Price Factors List